CARDIFF ONCOLOGY INC revenue breakdown overview

CARDIFF ONCOLOGY INC revenue for the last year amounted to 659.76 k EUR, the most of which — 442.13 k EUR — came from its highest performing source at the moment, Novel Therapies for Cancers, the year earlier bringing 360.66 k EUR. The greatest contribution to the revenue figure was made by United States — last year it brought CARDIFF ONCOLOGY INC 442.13 k EUR, and the year before that — 360.66 k EUR.